Medicare AdvantageCoverageMedium impact
MA06.004d, In Vivo Allergy Sensitivity Testing
Independence Blue Cross·Allergy & Immunology, Internal Medicine, Family Medicine +2 more·Medical Policy
Effective date
Aug 25, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage updated their medical necessity criteria for in vivo allergy sensitivity testing procedures. This policy change affects when these allergy tests will be considered medically necessary and covered by Medicare Advantage plans.
Action Required
By August 25, 2025: Billing and clinical teams must review updated medical necessity criteria for in vivo allergy sensitivity testing. Update documentation templates to ensure all allergy testing orders meet the new Medicare Advantage requirements. Verify medical necessity before performing tests to prevent claim denials.